Skip to main content
. 2020 May 6;9(5):1364. doi: 10.3390/jcm9051364

Table 5.

Results of the left ventricular hypertrophy * multivariable logistic regression analysis in the study population.

Variable Model 3 Model 4
OR Unstandardized 95% C.I. OR Standardized ** p OR Unstandardized 95% C.I. OR Standardized ** p
BPs, mmHg 1.012 0.997–1.027 1.242 0.120 - - - -
BPd, mmHg 1.010 0.983–1.038 1.112 0.461 - - - -
HR, bpm 0.988 0.964–1.012 0.871 0.316 0.984 0.960–1.010 0.840 0.224
LVEF BP, % 1.001 0.955–1.050 1.008 0.956 1.011 0.961–1.063 1.063 0.675
LAVI, ml/m2 1.047 1.011–1.084 1.381 0.009 1.048 1.010–1.088 1.389 0.014
P wave time, ms 1.027 1.001–1.055 1.341 0.042 1.022 0.995–1.050 1.261 0.118
QRS time, ms 1.048 1.014–1.084 1.553 0.006 1.046 1.010–1.082 1.517 0.012
Sokolow–Lyon index, mm 1.027 0.988–1.068 1.211 0.176 1.034 0.992–1.077 1.264 0.112
Cornell index, mm 1.082 1.029–1.137 1.525 0.002 1.071 1.017–1.128 1.443 0.010
Lewis index, mm 1.053 1.017–1.090 1.540 0.004 1.053 1.016–1.091 1.539 0.005
NT-proBNP, pg/mL 1.002 1.000–1.005 1.537 0.058 1.002 1.000–1.004 1.468 0.077
hs-TnT, pg/mL 1.078 1.014–1.147 1.453 0.016 1.081 1.012–1.156 1.472 0.021
Fasting glucose, mg/dL 1.011 1.000–1.023 1.224 0.056 1.011 0.997–1.025 1.218 0.132
120 min glucose, mg/dL 1.007 1.000–1.014 1.300 0.063 1.008 1.000–1.015 1.344 0.046
Fasting insulin, µUL/mL 1.011 0.975–1.048 1.079 0.555 1.019 0.981–1.060 1.145 0.329
120 Insulin, µUL/mL 1.002 0.999–1.006 1.154 0.231 1.003 0.999–1.008 1.236 0.103
HbA1c, % 1.961 1.299–2.961 1.460 0.001 2.127 1.212–3.731 1.528 0.009
HOMA -IR 1.045 0.936–1.167 1.100 0.434 1.063 0.942–1.199 1.142 0.322
hsCRP, mg/L 1.029 0.975–1.085 1.106 0.296 1.028 0.975–1.084 1.103 0.306
WHR 3.194 0.074–137.489 1.118 0.545 2.485 0.048–127.726 1.092 0.651
% fat 21.797 0.052–9204.292 1.261 0.318 16.272 0.031–8603.827 1.234 0.383
Total fat mass, kg 1.050 1.011–1.090 1.558 0.011 1.046 1.006–1.088 1.510 0.024
Total lean mass, kg 1.076 1.025–1.130 2.184 0.003 1.071 1.019–1.125 2.067 0.007
Android fat mass, kg 1.390 1.058–1.826 1.491 0.018 1.380 1.027–1.853 1.478 0.032
Gynoid fat mass, kg 1.406 1.104–1.793 1.609 0.006 1.384 1.082–1.771 1.573 0.010
Legs fat mass, kg 1.147 1.018–1.293 1.462 0.025 1.143 1.012–1.292 1.450 0.032
Visceral mass, kg 1.608 1.124–2.300 1.567 0.009 1.581 1.064–2.347 1.542 0.023
A/G fat mass ratio, % 1.013 0.997–1.030 1.350 0.112 1.013 0.995–1.031 1.340 0.151
G/T fat mass ratio, % 0.978 0.844–1.133 0.941 0.765 1.001 0.857–1.171 1.004 0.985
A/T fat mass ratio, % 1.232 1.028–1.476 1.572 0.024 1.246 1.026–1.512 1.610 0.026
Legs/T fat mass ratio, % 0.959 0.907–1.014 0.746 0.137 0.964 0.909–1.023 0.776 0.226
Risk SCORE, % 0.988 0.909–1.075 0.999 0.788 0.969 0.883–1.063 0.998 0.504

BPs: systolic blood pressure; BPd: diastolic blood pressure; mmHg: millimeters of mercury; HR: heart rate; bpm: beats per minute; LVEF BP: left ventricular ejection fraction biplane Simpson’s method; LAVI: left atrial volume index; NT-proBNP: N-terminal pro-brain natriuretic peptide; hs-TnT: high-sensitivity troponin T; HbA1c: hemoglobin A1c; HOMA-IR: homeostasis model assessment of insulin resistance; CRP: C-reactive protein; WHR: waist-hip ratio; A: android; G: gynoid, T: total; SCORE: Systematic Coronary Risk Estimation; GFR: glomerular filtration rate Cockcroft-Gault Equation; Model 3: adjusted for age, sex, GFR; Model 4: model 3 + additional adjustment for: history of hypertension, diabetes, atrial fibrillation, myocardial infarction, coronary heart disease, heart failure, peripheral artery disease, stroke and BP ≥ 140 and/or ≥ 90 mmHg. * The left ventricular mass (LVM) index was calculated by the formula LVM/BSA, and the LVH was defined as LVMI ≥ 115 g/m2 for men and ≥ 95 g/m2 for women. ** Standardized for independent variables.